Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Melioli

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Allergy|June 9, 2012
The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera stingP Bonadonna, R Zanotti, G Melioli, et al.
European Annals of Allergy and Clinical Immunology|February 25, 2012
Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosisR E Rossi, G Melioli, G Monasterolo, et al.
Anticancer Research|March 1, 1996
Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up studyG Ferlazzo, C Magno, R Iemmo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalentsM Dono, S Zupo, N Leanza, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cellsC Semino, G Ferlazzo, G Pietra, et al.
Immunological Reviews|October 1, 1989
Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humansA Moretta, E Ciccone, G Pantaleo, et al.
The American Review of Respiratory Disease|April 1, 1987
Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunityG A Rossi, R Felletti, B Balbi, et al.
Melanoma Research|March 21, 1998
Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot studyU M Reali, L Martini, L Borgognoni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 1, 1997
Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot studyG Ferlazzo, C Scisca, R Iemmo, et al.
Antibiotics and Chemotherapy|January 1, 1987
Recombinant DNA-coded antigens: second-generation tests for the diagnosis of HTLV-III infectionO E Varnier, G Pellizzari, F Lillo, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Allergy|June 9, 2012
The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera stingP Bonadonna, R Zanotti, G Melioli, et al.
European Annals of Allergy and Clinical Immunology|February 25, 2012
Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosisR E Rossi, G Melioli, G Monasterolo, et al.
Anticancer Research|March 1, 1996
Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up studyG Ferlazzo, C Magno, R Iemmo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalentsM Dono, S Zupo, N Leanza, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cellsC Semino, G Ferlazzo, G Pietra, et al.
Immunological Reviews|October 1, 1989
Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humansA Moretta, E Ciccone, G Pantaleo, et al.
The American Review of Respiratory Disease|April 1, 1987
Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunityG A Rossi, R Felletti, B Balbi, et al.
Melanoma Research|March 21, 1998
Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot studyU M Reali, L Martini, L Borgognoni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 1, 1997
Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot studyG Ferlazzo, C Scisca, R Iemmo, et al.
Antibiotics and Chemotherapy|January 1, 1987
Recombinant DNA-coded antigens: second-generation tests for the diagnosis of HTLV-III infectionO E Varnier, G Pellizzari, F Lillo, et al.
Pageof 12